Semax
Peptiva
Semax
ISKLJUČIVO ZA IN VITRO LABORATORIJSKA ISTRAŽIVANJA.
Nije namijenjen osobnoj, kliničkoj, dijagnostičkoj ili veterinarskoj primjeni niti primjeni na ljudima ili životinjama.
Description and specifications
What is Semax?
Semax is a synthetic peptide analog of a short ACTH fragment, stabilized by the addition of a Pro-Gly-Pro sequence. It is being researched in neurobiology, models of ischemic stress, and the regulation of neurotrophic factors.
Mechanism and Scientific Context
Semax does not possess the classical corticotropic activity of full-length ACTH. Proposed effects include changes in BDNF and other gene expression, monoamine modulation, and an impact on the oxidative and inflammatory response of nervous tissue.
Main Research Areas
- BDNF and neurotrophic signaling
- models of cerebral ischemia and neural stress
- learning, memory, and neural plasticity
- oxidative stress and neuroinflammatory markers
How to interpret research data?
When reading literature, verify the identity of the material tested, the type of model, and the study limitations. The existence of a paper on a molecule does not confirm the properties of this product or its batch. Findings from laboratory and animal models do not prove clinical benefit.
Available Peptiva Variants
- 20 mg · Lyophilized vial
- 20 mg · Research dispenser
Select the available variant and check its name, total content, and price. The photo is not a substitute for the declaration of the selected variant.
Packaging format and content
Research dispenser: the variant contains a fully pre-filled dispenser with the selected content, not just a separate replacement cartridge. The quantity stated with the variant refers to the total declared content, not the amount per individual use.
Lyophilized vial: the variant contains lyophilized material in a vial, without a dispenser. This description does not refer to bacteriostatic water or a separate empty container.
Storage and handling conditions depend on the specific formulation and batch declaration. The packaging format does not confirm sterility, dosing precision, stability, or suitability for human or animal application.
Important Limitations
Part of the literature is regional, and broader clinical confirmation remains limited. The product is not intended for the treatment of neurological conditions.
Batch Documentation
For inquiries about available COA documentation, please contact peptivacomhr@gmail.com with the product name and LOT number if known. The availability and scope of analyses are checked for the specific batch. COA does not by itself prove sterility or suitability for human or animal application.
Intended Use and Limitations: This product is intended solely for laboratory research. It is not intended for human or animal use, diagnosis, treatment, mitigation, or prevention of disease. The description is not medical advice. The research-use-only designation and packaging name do not by themselves determine the regulatory status of the product or prove its safety or sterility.
COA on request
To enquire about a certificate of analysis (COA), send the material name, requested variant and LOT / batch number if available. Documents are not published on this page.
Request a COA by emailThe button opens your email app with a prepared enquiry. You send the message yourself. peptivacomhr@gmail.com
A COA applies to a specific batch. A purity result alone does not establish sterility, absence of endotoxins or safety for use in humans or animals.